Life Sciences

Transforming Health Outcomes in Indiana

AnalytiXIN is spearheading a groundbreaking initiative to unite healthcare organizations, clinical researchers, and life sciences innovators across Indiana.

Creating an open, shared clinical-genomic
database for Indiana.

Our Clinical Genomic Database

This platform is built on collaboration, harnessing the strengths of organizations like Lilly, the Indiana University School of Medicine, Indiana University Health, the Indiana Biobank, and the Indiana Health Information Exchange. Together, we are driving forward disease-specific research and transformative clinical trials.

Transforming Clinical Research
in Indiana

Pioneering Disease-Specific Research

Our data asset powers both disease-specific and agnostic research to transform healthcare outcomes.

Driving Inclusive Clinical Trials

We strive to ensure clinical trials include diverse populations, addressing health disparities across Indiana.

Innovating Healthcare Solutions

By merging clinical and genomic data, we have the potential to extract profound insights to revolutionize patient care.

Building an Emerging Hub for Destination Medicine

We are attracting top-tier talent and positioning Indiana as a leader in healthcare innovation.

Since 2021, AnalytiXIN has sequenced 35,000 Indiana Biobank samples. By 2027, we plan to reach 100,000+

By 2025, we plan to reach

Why This Matters

Better Healthcare for People in Indiana

We’re building a large database of health information that helps doctors and researchers find better ways to treat diseases.

Big Investments for Big Impact

$16M has already been invested through public and private partnerships to drive healthcare improvements for people living in Indiana.

Faster Patient Participation

Thousands of patients have already joined the project! With their help, we’re growing faster than many other clinical-genomic databases, putting Indiana on the map for destination medicine.

Tracking Health Over Time

Our data includes health records that go back 30+ years, which helps researchers find patterns to improve medicine and treatments for the best outcomes for patients.

In the News

Lorem Ipsum Sit Dolor

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud.